You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
雅本化學(300261.SZ):與恒瑞醫藥簽署《供應戰略協議》
格隆匯 08-01 17:02

格隆匯8月1日丨雅本化學(300261.SZ)公佈,公司與恒瑞醫藥簽署《供應戰略協議》。雙方就建立面向未來的戰略合作伙伴關係達成框架性協議,以共同推動協議產品的技術創新與質量升級,強化醫藥產業鏈關鍵環節的協同競爭力,實現雙方在醫藥先進製造領域的價值共贏。雙方同意通過本協議建立以協議產品全生命週期協同管理為核心的戰略合作伙伴關係,共同構建涵蓋工藝研發、商業化生產及持續性改進的端到端協作機制。

本協議的履行將不僅帶來即期業務貢獻,更通過優化客户結構、提升抗風險能力、驗證綜合實力、深化業務佈局及強化品牌效應,為創新醫藥CDMO業務構築堅實的中長期增長基礎,驅動“2+X”戰略特別是創新醫藥核心支柱的加速發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account